Citation: European Neuropsychopharmacology
The Journal of the European College of Neuropsychopharmacology
Volume 21 (2011), Supplement 3, Page S221( Tuesday, 06 September 2011)
T. Sharp1, H. Hartung1, S. Tan2, V. Visser-Vandewalle2, Y. Temel2
1University of Oxford, Department of Pharmacology, Oxford, United Kingdom
2University of Maastricht, Department of Neuroscience and Neurosurgery, Maastricht, The Netherlands
High-frequency stimulation (HFS) of the STN is an established surgical therapy of advanced Parkinson's disease (PD). However, despite beneficial motor effects this procedure often causes debilitating psychiatric side-effects, including depressed mood [1], and is associated with increased suicide risk [2]. Depression is linked to changes in 5-hydroxytryptamine (5-HT) and previously we reported that, in animal models, STN HFS inhibited the firing of putative 5-HT neurons in the dorsal raphe nucleus (DRN) of the midbrain [3]. Here we have further investigated this phenomenon using a combination of in vivo electrophysiological and neurochemical studies.
STN HFS caused a clear-cut inhibition (20–30%) in the majority of DRN neurons but a smaller proportion of neurons were either excited or non-responsive. Juxtacellular labelling studies demonstrated 5-HT-immunopositive neurons in each of these response categories. In microdialysis experiments STN HFS evoked a modest (25%) fall in extracellular 5-HT (prefrontal cortex and striatum) in both anaesthetised and awake animals. Previous anatomical studies demonstrate STN-DRN connections via the lateral habenula (LHb), which is increasingly implicated in the neural circuitry of depression. Interestingly, STN HFS increased c-fos expression in the LHb, and also increased neuronal firing in this nucleus.
These data demonstrate a powerful modulatory effect of STN HFS on 5-HT neurons but suggest destabilisation rather than simple inhibition. The data implicate the LHb in the neural circuitry mediating this effect. Altered function of STN-DRN neural connectivity may contribute to the adverse psychiatric effects of STN HFS in PD patients, and to mood disturbances in PD patients more generally.
References:
1. Temel Y., Kessels A., Tan S., Topdag A., Boon P., Visser-Vandewalle V., 2006, Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord. 12, 265–272.
2. Voon V., Krack P., Lang A.E. et al, 2008, A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131, 2720–2728.
3. Temel Y., Boothman L.J., Blokland A., Magill P.J., Steinbusch H.W., Visser-Vandewalle V., Sharp T., 2007, Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci 104, 17087–17092.
The Journal of the European College of Neuropsychopharmacology
Volume 21 (2011), Supplement 3, Page S221( Tuesday, 06 September 2011)
T. Sharp1, H. Hartung1, S. Tan2, V. Visser-Vandewalle2, Y. Temel2
1University of Oxford, Department of Pharmacology, Oxford, United Kingdom
2University of Maastricht, Department of Neuroscience and Neurosurgery, Maastricht, The Netherlands
High-frequency stimulation (HFS) of the STN is an established surgical therapy of advanced Parkinson's disease (PD). However, despite beneficial motor effects this procedure often causes debilitating psychiatric side-effects, including depressed mood [1], and is associated with increased suicide risk [2]. Depression is linked to changes in 5-hydroxytryptamine (5-HT) and previously we reported that, in animal models, STN HFS inhibited the firing of putative 5-HT neurons in the dorsal raphe nucleus (DRN) of the midbrain [3]. Here we have further investigated this phenomenon using a combination of in vivo electrophysiological and neurochemical studies.
STN HFS caused a clear-cut inhibition (20–30%) in the majority of DRN neurons but a smaller proportion of neurons were either excited or non-responsive. Juxtacellular labelling studies demonstrated 5-HT-immunopositive neurons in each of these response categories. In microdialysis experiments STN HFS evoked a modest (25%) fall in extracellular 5-HT (prefrontal cortex and striatum) in both anaesthetised and awake animals. Previous anatomical studies demonstrate STN-DRN connections via the lateral habenula (LHb), which is increasingly implicated in the neural circuitry of depression. Interestingly, STN HFS increased c-fos expression in the LHb, and also increased neuronal firing in this nucleus.
These data demonstrate a powerful modulatory effect of STN HFS on 5-HT neurons but suggest destabilisation rather than simple inhibition. The data implicate the LHb in the neural circuitry mediating this effect. Altered function of STN-DRN neural connectivity may contribute to the adverse psychiatric effects of STN HFS in PD patients, and to mood disturbances in PD patients more generally.
References:
1. Temel Y., Kessels A., Tan S., Topdag A., Boon P., Visser-Vandewalle V., 2006, Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord. 12, 265–272.
2. Voon V., Krack P., Lang A.E. et al, 2008, A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131, 2720–2728.
3. Temel Y., Boothman L.J., Blokland A., Magill P.J., Steinbusch H.W., Visser-Vandewalle V., Sharp T., 2007, Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci 104, 17087–17092.
Aujourd'hui à 16:26 par guiguisnaaap
» Livres Médicales - iKB Orthopédie - Traumatologie 2019
Aujourd'hui à 16:25 par guiguisnaaap
» Atlas De Poche De Mycologie
Hier à 18:29 par SAMSON KF
» VIDAL Mobile L'APPLICTION 2022 (la version payante de « Vidal Mobile » gratuitement) #Application #Pharmacologie
Jeu 25 Avr 2024, 19:50 par moonshadow92
» 50 Dossiers Cardiologie, Cas cliniques corrigés
Mer 24 Avr 2024, 20:21 par Urjee
» Précis de dermatologie esthétique: Améliorer l'esthétique du visage #Dermatologie Elsevier Masson; Illustrated édition (5 janvier 2022)
Mer 24 Avr 2024, 09:41 par dr.boudiaf
» EMC -Techniques Chirurgicales 2020 7 en 1 livre (Tête & cou -Chirurgie plastique-Thorax -Appareil digestif -Gynécologie - urologie Chirurgie vasculaire édition sba-medecine 2020 (avec misa à jour 2020) #collections
Mar 23 Avr 2024, 23:07 par Dr.Abbes
» VIDAL 2018 - Le dictionnaire des médicaments
Mar 23 Avr 2024, 16:31 par abuabderrahmen
» Anesthésie-réanimation en chirurgie thoracique + Anesthésie-réanimation en chirurgie cardiaque
Mar 23 Avr 2024, 09:22 par drboudhir
» [Collection] Livres pour le praticien #collections
Mar 23 Avr 2024, 08:45 par chembou norbert
» Livres Médicales - Cas Difficiles En Medecine Interne
Mar 23 Avr 2024, 08:43 par chembou norbert
» 77 GESTES ET TECHNIQUES pratiqués chez l'enfant en PÉDIATRIE #Pédiatrie
Lun 22 Avr 2024, 23:03 par edwards
» Guide Pratique de Médecine d'Urgence , Réanimation et Soins Intensifs
Dim 21 Avr 2024, 21:44 par zoblo
» Jean-Jacques Lehot, Charles Arvieux, "Réanimation et urgences"
Dim 21 Avr 2024, 21:41 par zoblo
» Livres Médicales – Maitriser la Radiographie du Thorax
Dim 21 Avr 2024, 16:05 par *Panda Kealong